Waters Corporation (NYSE:WAT) Receives Hold Rating from Cowen and Company

Waters Corporation (NYSE:WAT)‘s stock had its “hold” rating reaffirmed by Cowen and Company in a report released on Friday, November 3rd. They currently have a $190.00 target price on the medical instruments supplier’s stock. Cowen and Company’s target price would indicate a potential downside of 2.38% from the company’s previous close.

WAT has been the subject of a number of other reports. Zacks Investment Research raised shares of Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target for the company in a research report on Thursday, July 13th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Waters Corporation in a research note on Tuesday, September 26th. They issued a “hold” rating and a $180.00 price target on the stock. BidaskClub raised shares of Waters Corporation from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 16th. Jefferies Group LLC reaffirmed a “hold” rating and set a $175.00 target price on shares of Waters Corporation in a research note on Thursday, July 27th. Finally, Morgan Stanley reaffirmed an “underweight” rating and set a $183.00 target price (up previously from $174.00) on shares of Waters Corporation in a research note on Wednesday, July 26th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $193.62.

Waters Corporation (NYSE:WAT) opened at $194.64 on Friday. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The company has a market cap of $15,366.58, a PE ratio of 26.83, a PEG ratio of 2.80 and a beta of 0.83. Waters Corporation has a 1-year low of $133.35 and a 1-year high of $199.78.

Waters Corporation (NYSE:WAT) last issued its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.57 EPS. research analysts predict that Waters Corporation will post 7.42 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.truebluetribune.com/2017/11/14/cowen-and-company-reiterates-hold-rating-for-waters-corporation-wat.html.

In other Waters Corporation news, SVP Rohit Khanna sold 26,913 shares of the stock in a transaction on Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the transaction, the senior vice president now owns 13,677 shares in the company, valued at $2,707,088.61. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Elizabeth B. Rae sold 12,000 shares of the stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $197.95, for a total value of $2,375,400.00. Following the completion of the transaction, the senior vice president now owns 18,129 shares of the company’s stock, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,313 shares of company stock valued at $11,120,642. 5.07% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Magnetar Financial LLC acquired a new stake in Waters Corporation in the 3rd quarter worth about $720,000. AMP Capital Investors Ltd raised its holdings in shares of Waters Corporation by 8.6% in the 3rd quarter. AMP Capital Investors Ltd now owns 31,994 shares of the medical instruments supplier’s stock worth $5,743,000 after purchasing an additional 2,538 shares during the period. Allianz Asset Management GmbH raised its holdings in shares of Waters Corporation by 7.7% in the 3rd quarter. Allianz Asset Management GmbH now owns 4,179 shares of the medical instruments supplier’s stock worth $750,000 after purchasing an additional 298 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its holdings in shares of Waters Corporation by 3.2% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 13,075 shares of the medical instruments supplier’s stock worth $2,357,000 after purchasing an additional 400 shares during the period. Finally, Envestnet Asset Management Inc. raised its holdings in shares of Waters Corporation by 11.1% in the 3rd quarter. Envestnet Asset Management Inc. now owns 3,781 shares of the medical instruments supplier’s stock worth $675,000 after purchasing an additional 377 shares during the period. 91.82% of the stock is currently owned by institutional investors and hedge funds.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Analyst Recommendations for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply